1. Home
  2. HCTI vs VIRX Comparison

HCTI vs VIRX Comparison

Compare HCTI & VIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCTI
  • VIRX
  • Stock Information
  • Founded
  • HCTI 2020
  • VIRX 2007
  • Country
  • HCTI United States
  • VIRX United States
  • Employees
  • HCTI N/A
  • VIRX N/A
  • Industry
  • HCTI Retail: Computer Software & Peripheral Equipment
  • VIRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCTI Technology
  • VIRX Health Care
  • Exchange
  • HCTI Nasdaq
  • VIRX Nasdaq
  • Market Cap
  • HCTI 6.8M
  • VIRX 6.3M
  • IPO Year
  • HCTI 2021
  • VIRX N/A
  • Fundamental
  • Price
  • HCTI $0.83
  • VIRX $0.23
  • Analyst Decision
  • HCTI
  • VIRX Buy
  • Analyst Count
  • HCTI 0
  • VIRX 4
  • Target Price
  • HCTI N/A
  • VIRX $5.00
  • AVG Volume (30 Days)
  • HCTI 315.0K
  • VIRX 3.8M
  • Earning Date
  • HCTI 11-14-2024
  • VIRX 11-13-2024
  • Dividend Yield
  • HCTI N/A
  • VIRX N/A
  • EPS Growth
  • HCTI N/A
  • VIRX N/A
  • EPS
  • HCTI N/A
  • VIRX N/A
  • Revenue
  • HCTI $16,565,999.00
  • VIRX N/A
  • Revenue This Year
  • HCTI $88.31
  • VIRX N/A
  • Revenue Next Year
  • HCTI N/A
  • VIRX N/A
  • P/E Ratio
  • HCTI N/A
  • VIRX N/A
  • Revenue Growth
  • HCTI N/A
  • VIRX N/A
  • 52 Week Low
  • HCTI $0.29
  • VIRX $0.13
  • 52 Week High
  • HCTI $4.24
  • VIRX $1.31
  • Technical
  • Relative Strength Index (RSI)
  • HCTI 49.04
  • VIRX 60.26
  • Support Level
  • HCTI $0.76
  • VIRX $0.14
  • Resistance Level
  • HCTI $0.99
  • VIRX $0.19
  • Average True Range (ATR)
  • HCTI 0.18
  • VIRX 0.03
  • MACD
  • HCTI 0.00
  • VIRX 0.01
  • Stochastic Oscillator
  • HCTI 26.28
  • VIRX 83.12

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments which are Software Services, Managed Services, and Support and Platform Services.

About VIRX Viracta Therapeutics Inc.

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

Share on Social Networks: